Royal Bank of Canada’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $48K | Buy |
1,686
+1,644
| +3,914% | +$35.8K | ﹤0.01% | 5817 |
|
|
2026
Q1 | $1K | Sell |
42
-1,444
| -97% | -$27.3K | ﹤0.01% | 6836 |
|
|
2025
Q4 | $28K | Sell |
1,486
-13,344
| -90% | -$224K | ﹤0.01% | 5858 |
|
|
2025
Q3 | $216K | Sell |
14,830
-45,618
| -75% | -$650K | ﹤0.01% | 5045 |
|
|
2025
Q2 | $1.18M | Buy |
60,448
+20,835
| +53% | +$370K | ﹤0.01% | 3751 |
|
|
2025
Q1 | $703K | Sell |
39,613
-3,413
| -8% | -$73.5K | ﹤0.01% | 3740 |
|
|
2024
Q4 | $921K | Buy |
43,026
+3,248
| +8% | +$79K | ﹤0.01% | 3600 |
|
|
2024
Q3 | $1.24M | Buy |
39,778
+7,846
| +25% | +$195K | ﹤0.01% | 3357 |
|
|
2024
Q2 | $496K | Buy |
31,932
+30,694
| +2,479% | +$371K | ﹤0.01% | 4022 |
|
|
2024
Q1 | $13K | Sell |
1,238
-15,238
| -92% | -$152K | ﹤0.01% | 6090 |
|
|
2023
Q4 | $198K | Buy |
16,476
+7,561
| +85% | +$61.9K | ﹤0.01% | 5108 |
|
|
2023
Q3 | $62K | Buy |
8,915
+485
| +6% | +$4.48K | ﹤0.01% | 5654 |
|
|
2023
Q2 | $71K | Buy |
8,430
+4,726
| +128% | +$39.4K | ﹤0.01% | 5577 |
|
|
2023
Q1 | $34K | Sell |
3,704
-6,150
| -62% | -$78.7K | ﹤0.01% | 5811 |
|
|
2022
Q4 | $112K | Sell |
9,854
-71,982
| -88% | -$1.07M | ﹤0.01% | 5361 |
|
|
2022
Q3 | $1.39M | Sell |
81,836
-17,608
| -18% | -$378K | ﹤0.01% | 3148 |
|
|
2022
Q2 | $2.14M | Buy |
99,444
+2,264
| +2% | +$62.8K | ﹤0.01% | 2830 |
|
|
2022
Q1 | $3.6M | Buy |
97,180
+4,169
| +4% | +$162K | ﹤0.01% | 2537 |
|
|
2021
Q4 | $4.23M | Buy |
93,011
+4,298
| +5% | +$224K | ﹤0.01% | 2509 |
|
|
2021
Q3 | $5.62M | Buy |
88,713
+31,891
| +56% | +$2.43M | ﹤0.01% | 2212 |
|
|
2021
Q2 | $5.2M | Buy |
56,822
+6,520
| +13% | +$518K | ﹤0.01% | 2290 |
|
|
2021
Q1 | $3.42M | Sell |
50,302
-10,090
| -17% | -$783K | ﹤0.01% | 2541 |
|
|
2020
Q4 | $4.37M | Sell |
60,392
-4,628
| -7% | -$268K | ﹤0.01% | 2277 |
|
|
2020
Q3 | $2.47M | Buy |
65,020
+8,277
| +15% | +$279K | ﹤0.01% | 2513 |
|
|
2020
Q2 | $2.01M | Sell |
56,743
-2,232
| -4% | -$63.5K | ﹤0.01% | 2605 |
|
|
2020
Q1 | $1.29M | Sell |
58,975
-2,708
| -4% | -$60.7K | ﹤0.01% | 2837 |
|
|
2019
Q4 | $1.33M | Buy |
61,683
+15,153
| +33% | +$348K | ﹤0.01% | 3224 |
|
|
2019
Q3 | $1.05M | Buy |
46,530
+13,196
| +40% | +$365K | ﹤0.01% | 3307 |
|
|
2019
Q2 | $1.2M | Buy |
33,334
+30,823
| +1,228% | +$987K | ﹤0.01% | 3159 |
|
|
2019
Q1 | $79K | Buy |
2,511
+867
| +53% | +$25.3K | ﹤0.01% | 4907 |
|
|
2018
Q4 | $41K | Buy |
1,644
+590
| +56% | +$15.2K | ﹤0.01% | 5201 |
|
|
2018
Q3 | $30K | Buy |
1,054
+1,011
| +2,351% | +$18.9K | ﹤0.01% | 5472 |
|
|
2018
Q2 | $1K | Buy |
+43
| New | +$493 | ﹤0.01% | 6338 |
|
|
2017
Q4 | – | Sell |
-7
| Closed | – | – | 6554 |
|
|
2017
Q3 | $0 | Buy |
+7
| New | +$15 | ﹤0.01% | 6719 |
|
Other funds holding CDNA
DM
AIM
GS
Royal Bank of Canada's CDNA Position: Q2 2026 in Review
Royal Bank of Canada increased its CareDx (CDNA) stake by 3,914% in Q2 2026, buying an estimated $35.8K and bringing the position to 1,686 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #5817.
Royal Bank of Canada first reported a position in CDNA in Q3 2017 and has held it in 34 quarters since. The position peaked at $5.62M in Q3 2021. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Royal Bank of Canada held 1,686 shares of CareDx worth $48K as of Q2 2026.
- Royal Bank of Canada bought 1,644 CareDx shares in Q2 2026, an estimated $35.8K.
- CareDx made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #5817 holding.
- Royal Bank of Canada first reported a position in CareDx in Q3 2017 and has held it in 34 quarters since.
- Royal Bank of Canada's CareDx position peaked at $5.62M in Q3 2021.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.